20
Feb

When Furiex posted positive Phase III data on its lead drug, the biotech did everything just short of posting a “for sale” sign in its front yard to signal its intentions as its market cap more than doubled in a matter of hours. Now, in case you missed the signals, Bloomberg is reporting its sources are saying that the company has signed on with Bank of America to engineer a deal.

…read more

Source: Is it news to you? Furiex really is up on the auction block

    

0 No comments